BioAgilytix Labs
Financials
Estimates*
USD | 2017 |
---|---|
Revenues | 35.9m |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
* | N/A | Acquisition | |
$30.1m | Growth Equity VC | ||
* | N/A | Buyout | |
Total Funding | €27.4m |
Recent News about BioAgilytix Labs
EditBioAgilytix is a specialized bioanalytical laboratory that provides advanced testing services primarily for the pharmaceutical, biotechnology, and agricultural biotechnology industries. The company operates globally, with a significant presence in Europe through its laboratory in Hamburg, Germany. BioAgilytix focuses on supporting all phases of large molecule studies, which are essential for developing new drugs and therapies.
The company offers a comprehensive suite of assays, which are tests used to measure the presence, amount, or activity of a substance. These include pharmacokinetics (PK) and pharmacodynamics (PD) assays, which study how drugs move through and affect the body. They also provide cell-based assays, which are tests conducted on living cells to understand drug effects, and immunogenicity assays, which evaluate the immune response to drugs.
BioAgilytix serves clients in the pharmaceutical and biotech sectors, helping them develop and validate new treatments. They also support agricultural biotechnology companies by providing testing services that ensure the safety and efficacy of agricultural products. The company has also been instrumental in COVID-19 testing, offering customizable testing packages to help manage and prevent the spread of the virus.
The business model of BioAgilytix is service-based. They generate revenue by offering specialized testing services to their clients. These services are critical for the development and approval of new drugs and therapies, making BioAgilytix an essential partner for companies in the life sciences sector.
In summary, BioAgilytix is a key player in the bioanalytical testing market, providing essential services that support drug development and safety. Their expertise in large molecule studies, coupled with their global reach, positions them as a valuable resource for pharmaceutical, biotech, and agricultural biotechnology companies.
Keywords: bioanalytical, pharmacokinetics, pharmacodynamics, immunogenicity, cell-based assays, COVID-19 testing, pharmaceutical, biotechnology, agricultural biotechnology, global studies.